NONOF (NONOF) Stock Price & Analysis
NONOF (NONOF) rose 0.85% to USD 41.6 as of June 9, 2026 at 23:53 UTC, according to Nexqual real-time market data.
NONOF last closed at USD 41.25; the session ranged USD 41.6–41.6 on volume of 300 shares. Market capitalization is $184.25B, with a 52-week range of USD 34–82.5 (PNK). Source: Nexqual, June 9, 2026 at 23:53 UTC.
Key Statistics (as of June 9, 2026 at 23:53 UTC)
| Price | USD 41.6 |
|---|---|
| Change | ▲ 0.85% (up) |
| Previous Close | USD 41.25 |
| Open | USD 41.6 |
| Day Range | USD 41.6 – 41.6 |
| 52-Week Range | USD 34 – 82.5 |
| Volume | 300 shares |
| Market Cap | $184.25B |
| Exchange | PNK |
Technical Analysis (NONOF)
Nexqual's technical model rates NONOF "SELL" based on 2 bullish and 4 bearish signals across 124 daily candles, as of June 9, 2026 at 23:53 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.28 (neutral) |
| vs SMA50 | Above (USD 41.57) |
| MACD | -0.05 (negative) |
Analyst Ratings (NONOF)
Wall Street analysts rate NONOF "None" based on 1 analysts, with a mean price target of USD 53.49 (range USD 53.49–53.49), per Nexqual as of June 9, 2026 at 23:53 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 53.49 |
| High Target | USD 53.49 |
| Low Target | USD 53.49 |
Earnings (NONOF)
| Next Earnings Date | 2026-08-05 |
|---|---|
| Revenue Estimate | $72.07B |
Source: Nexqual, June 9, 2026 at 23:53 UTC.
Financials & Fundamentals (NONOF)
| Total Revenue | $327.80B |
|---|---|
| Revenue Growth (YoY) | +24.00% |
| Gross Margin | +83.20% |
| Operating Margin | +61.57% |
| Profit Margin | +37.21% |
| ROE | +71.40% |
| Debt / Equity | 72.09 |
| Current Ratio | 0.79 |
| Total Cash | $21.63B |
| Total Debt | $146.38B |
| Free Cash Flow | $-12.04B |
Source: Nexqual, June 9, 2026 at 23:53 UTC.
Financial Health Score (NONOF)
Nexqual rates NONOF's overall financial health "Solid" across five dimensions, as of June 9, 2026 at 23:53 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 83%, operating 62% |
| Balance Sheet | Mixed — $21.6B cash vs $146.4B debt |
| Cash Flow | Weak — FCF negative: -$12.0B, burning cash |
| Efficiency | Strong — ROE 71%, ROA 19.2% |
Ownership (NONOF)
| Insider Ownership | +5.28% |
|---|---|
| Institutional Ownership | +33.51% |
| Shares Outstanding | 3.35B |
| Float | 3.19B |
Source: Nexqual, June 9, 2026 at 23:53 UTC.
Leadership (NONOF)
NONOF is led by Maziar Mike Doustdar B.A. (age 55), President, CEO & Member of the Management Board, per Nexqual as of June 9, 2026 at 23:53 UTC.
| President, CEO & Member of the Management Board | Maziar Mike Doustdar B.A. (age 55) |
|---|---|
| Executive VP, CFO & Member of the Management Board | Karsten Munk Knudsen (age 54) |
| EVP of R & D, Chief Scientific Officer and Member of the Management Board | Martin Holst Lange (age 55) |
Major Backers & Investors (NONOF)
Notable institutional backers of NONOF include EuroPacific Growth Fund-EUPAC Fund, Capital Group, Income Fund of America, according to Nexqual as of June 9, 2026 at 23:53 UTC.
Active Investors
| Investor | Stake |
|---|---|
| EuroPacific Growth Fund-EUPAC Fund | 0.95% |
| Capital Group | 0.7% |
| Income Fund of America | 0.46% |
| Dodge & Cox Funds-Dodge & Cox International Stock Fund | 0.39% |
| NEW PERSPECTIVE FUND | 0.36% |
| Capital Income Builder | 0.36% |
| Fidelity | 0.35% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.27% |
| BlackRock | 0.68% |
Source: Nexqual, June 9, 2026 at 23:53 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NVSEF | Novartis AG | USD 148.8 | ▲ 2.71% |
| RHHVF | Roche Holding Ltd | USD 409 | ▼ 1.3% |
| RHHBF | Roche Holding Ltd | USD 409 | ▲ 0.22% |
| ASMLF | ASML Holding N.V. | USD 1,765.34 | ▲ 8.9% |
| LRLCF | L'Oreal Co. | USD 435 | ▲ 1.3% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:53 UTC. This page is informational and not investment advice.